还是不涨，有什么用_老虎社区_美港股上老虎

woosu
2020-11-10

还是不涨，有什么用

5 Value Stocks To Watch In The Healthcare Sector

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.

5 Value Stocks To Watch In The Healthcare Sector

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":305539637,"tweetId":"305539637","gmtCreate":1605009001929,"gmtModify":1703835718726,"author":{"id":3552780443992615,"idStr":"3552780443992615","authorId":3552780443992615,"authorIdStr":"3552780443992615","name":"woosu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>还是不涨，有什么用</p></body></html>","htmlText":"<html><head></head><body><p>还是不涨，有什么用</p></body></html>","text":"还是不涨，有什么用","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/305539637","repostId":2082869701,"repostType":2,"repost":{"id":"2082869701","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1604935821,"share":"https://www.laohu8.com/m/news/2082869701?lang=&edition=full","pubTime":"2020-11-09 23:30","market":"us","language":"en","title":"5 Value Stocks To Watch In The Healthcare Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2082869701","media":"Benzinga","summary":"What are Value Stocks?\n\nA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.","content":"<html><body><h1>What are Value Stocks?</h1>\n<p>A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.</p>\n<h2>Below is a list of notable value stocks in the healthcare sector:</h2>\n<ol>\n<li><strong>SELLAS Life Sciences Gr</strong> (NASDAQ:SLS) - P/E: 0.62</li>\n<li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus Pharmaceuticals</a></strong> (NASDAQ:SUPN) - P/E: 9.78</li>\n<li><strong>Ocugen</strong> (NASDAQ:OCGN) - P/E: 0.04</li>\n<li><strong>Oncternal Therapeutics</strong> (NASDAQ:ONCT) - P/E: 4.61</li>\n<li><strong>Coherus BioSciences</strong> (NASDAQ:CHRS) - P/E: 7.01</li>\n</ol>\n<p>SELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Most recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Ocugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Most recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Coherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.</p>\n</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Value Stocks To Watch In The Healthcare Sector</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Value Stocks To Watch In The Healthcare Sector\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2020-11-09 23:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><h1>What are Value Stocks?</h1>\n<p>A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.</p>\n<h2>Below is a list of notable value stocks in the healthcare sector:</h2>\n<ol>\n<li><strong>SELLAS Life Sciences Gr</strong> (NASDAQ:SLS) - P/E: 0.62</li>\n<li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus Pharmaceuticals</a></strong> (NASDAQ:SUPN) - P/E: 9.78</li>\n<li><strong>Ocugen</strong> (NASDAQ:OCGN) - P/E: 0.04</li>\n<li><strong>Oncternal Therapeutics</strong> (NASDAQ:ONCT) - P/E: 4.61</li>\n<li><strong>Coherus BioSciences</strong> (NASDAQ:CHRS) - P/E: 7.01</li>\n</ol>\n<p>SELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Most recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Ocugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Most recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>Coherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p>\n<p>These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.</p>\n</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SLS":"SELLAS Life Sciences Group Inc.","CHRS":"Coherus Biosciences","ONCT":"Oncternal Therapeutics, Inc.","OCGN":"Ocugen","SUPN":"Supernus Pharmaceuticals"},"source_url":"https://www.benzinga.com/node/18273686","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2082869701","content_text":"What are Value Stocks?\nA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.\nBelow is a list of notable value stocks in the healthcare sector:\n\nSELLAS Life Sciences Gr (NASDAQ:SLS) - P/E: 0.62\nSupernus Pharmaceuticals (NASDAQ:SUPN) - P/E: 9.78\nOcugen (NASDAQ:OCGN) - P/E: 0.04\nOncternal Therapeutics (NASDAQ:ONCT) - P/E: 4.61\nCoherus BioSciences (NASDAQ:CHRS) - P/E: 7.01\n\nSELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nMost recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nOcugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nMost recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nCoherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nThese 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1183,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}